NDAQ:COCP - Post Discussion
Post by
schoolofrock on Sep 03, 2020 10:36am
Strategic decision to discontinue development of pimodivir
The Janssen Pharmaceutical announced a strategic decision to discontinue the development of pimodivir, a Phase 3 clinical asset. What does it mean? More at:
https://www.channelchek.com/news-channel/Cocrystal_Pharma_Inc.__COCP____The_High_Unmet_Need_Persists_in_Influenza
Be the first to comment on this post